Sartorius Aktiengesellschaft (LON:0NIQ)
180.60
+0.60 (0.33%)
Feb 12, 2026, 11:09 AM GMT
LON:0NIQ Revenue
Sartorius Aktiengesellschaft had revenue of 843.20M EUR in the quarter ending September 30, 2025, with 6.25% growth. This brings the company's revenue in the last twelve months to 3.52B, up 5.82% year-over-year. In the year 2024, Sartorius Aktiengesellschaft had annual revenue of 3.38B, down -0.44%.
Revenue (ttm)
3.52B EUR
Revenue Growth
+5.82%
P/S Ratio
3.93
Revenue / Employee
253.44K EUR
Employees
13,878
Market Cap
12.06B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.38B | -15.00M | -0.44% |
| Dec 31, 2023 | 3.40B | -779.00M | -18.66% |
| Dec 31, 2022 | 4.17B | 725.50M | 21.03% |
| Dec 31, 2021 | 3.45B | 1.11B | 47.68% |
| Dec 31, 2020 | 2.34B | 508.69M | 27.84% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.64B |
| GSK plc | 32.67B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| Convatec Group | 1.72B |
| CVS Group | 673.20M |
| Genus | 672.80M |
Sartorius Aktiengesellschaft News
- 8 days ago - Sartorius Aktiengesellschaft 2025 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 9 days ago - Sartorius AG (SUVPF) (Q4 2025) Earnings Call Highlights: Strong Revenue Growth and ... - GuruFocus
- 9 days ago - Sartorius Aktiengesellschaft (SOAGY) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 9 days ago - Preliminary Q4 2025 Sartorius AG and Sartorius Stedim Biotech SA Earnings Call Transcript - GuruFocus
- 9 days ago - Sartorius Group Preliminary FY25 Profit Rises - Nasdaq
- 9 days ago - Sartorius Aktiengesellschaft Non-GAAP EPS of €4.78, revenue of €3.54B; initiates FY26 outlook - Seeking Alpha
- 3 months ago - Sartorius: Consistent Performance And Market Resurgence - Valuation Falls - Seeking Alpha
- 3 months ago - 7 Stocks Taking The Next Step To Be On Offense - Seeking Alpha